Company intelligence

Drug Farm

Drug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.

BiotechShanghai, China / New York, NYFounded 2015
Last verified Jul 31, 2026

Key Metrics

Total funding
$138M
As of Jul 31, 2026Value Add Pulse research

Company Snapshot

Drug Farm is a Biotech company, based in Shanghai, China / New York, NY, founded 2015. Total funding $138M (As of Jul 31, 2026).

Investors

Latest Pulse

  1. What Post-H1 Funding Data Already Shows for Q3Helsing, Gauntlet and Drug Farm's rounds this week are early evidence that H1 2026's concentration pattern -- record capital, AI capturing 86%, the top five managers taking 73.1% -- is continuing into Q3, not reversing.โ†’
  2. Drug Farm Raises $55M Series D for Rare Disease DrugBiotech Drug Farm raised a $55 million Series D to advance DF-003, a Phase 3 ALPK1 inhibitor for rare autoinflammatory disorder ROSAH syndrome, alongside DF-006, a Phase 2 immunomodulator for hepatitis B and liver cancer.โ†’

Coverage Timeline

newest first
  1. FUNDINGWhat Post-H1 Funding Data Already Shows for Q3โ†’
  2. FUNDINGDrug Farm Raises $55M Series D for Rare Disease Drugโ†’

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from
  • Value Add Pulse researchValue Add VC data1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ยท Suggest a correction